Trials / NCT04926129
Natural History of the Progression of X-Linked Retinitis Pigmentosa
Completed Observational Natural history / observational
- Sponsor
- NightstaRx Ltd, a Biogen Company
- Treatment
- Other: Assessments
- Gene
- RPGR
- Conditions
- X-Linked Retinitis Pigmentosa
- Ages
- 7 Years to no upper limit
- Enrollment
- 201 participants
- Started
- 2017-09-13
- Main results expected
- 2022-12-16
- Results posted
- Not yet
- Record last updated
- 2023-02-10
What the study is testing
The objective of the study is to gain a better understanding of disease progression over time in participants with X-linked retinitis pigmentosa (XLRP).
Where it runs
Canada (2)
- Research Site, Montreal, Quebec
- Research Site, Vancouver
Finland (1)
- Research Site, Helsinki
France (1)
- Research Site, Montpellier
Germany (2)
- Research Site, Bonn
- Research Site, Tübingen
Netherlands (2)
- Research Site, Leiden
- Research Site, Nijmegen
United Kingdom (4)
- Research Site, Leeds
- Research Site, Manchester
- Research Site, Oxford
- Research Site, Southampton
United States (10)
- Research Site, Phoenix, Arizona
- Research Site, Los Angeles, California
- Research Site, San Francisco, California
- Research Site, Miami, Florida
- Research Site, New York, New York
- Research Site, Portland, Oregon
- Research Site, Dallas, Texas
- Research Site, Houston, Texas
- Research Site, Salt Lake City, Utah
- Research Site, Madison, Wisconsin